Article

PerTurboID, a targeted in situ method reveals the impact of kinase deletion on its local…

eLife · 2023 · Heledd Davies, author Hugo Belda, author Malgorzata Broncel, author Jill Dalimot, author Moritz Treeck, author ([email protected], [email protected]) Dominique Soldati-Favre, editor Dominique Soldati-Favre, senior_editor

Key facts

Title PerTurboID, a targeted in situ method reveals the impact of kinase deletion on its local protein environment in the cytoadhesion complex of malaria-causing parasites
First author Heledd Davies, author Hugo Belda, author Malgorzata Broncel, author Jill Dalimot, author Moritz Treeck, author ([email protected], [email protected]) Dominique Soldati-Favre, editor Dominique Soldati-Favre, senior_editor
Journal eLife
Published Sep 22, 2023
DOI 10.7554/eLife.86367
Devices mentioned BK110039, DEN000008, K022086, K103302, K800781
Product codes mentioned JCI, KIT, MVU, NDS, NJT, OOI, KIS, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature